Greece launches first biotech park in SE Europe with €80M ELPEN investment

ELPEN, a Greek pharmaceutical company, is investing €80 million to establish the Athens LifeTech Park, the first biotechnology park in Greece and Southeastern Europe. The park will include laboratories, preclinical and clinical research services, startup infrastructure, and a training center. This marks a significant step for regional biotech R&D capacity, though its operational timeline and impact remain to be seen.